• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE (SYNVISC ONE); INTRA-ARTICULAR HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE (SYNVISC ONE); INTRA-ARTICULAR HYALURONIC ACID Back to Search Results
Lot Number S13061
Device Problem Insufficient Information (3190)
Patient Problem Death (1802)
Event Type  Death  
Event Description
This solicited device case was received on (b)(6) 2014 from a patient via (b)(6).Patient id: (b)(6).Study title: (b)(6).No relevant medical history, past drugs, concomitant medications and concurrent conditions were reported.On (b)(6) 2014, the patient initiated treatment with synvisc one injection, at a dose of 6 ml once (route and expiration date not provided and batch/lot number: s13061) for osteoarthritis.On unknown date, the patient died due to unspecified reason.It was unknown if an autopsy was performed.Corrective treatment: no corrective treatment was provided.A pharmaceutical technical complaint (ptc) was initiated and conclusion was pending for the same.Reporter's causality assessment: not reported.Company causality assessment: associated.
 
Manufacturer Narrative
Pharmacovigilance comment: sanofi company comment dated (b)(6) 2014: this is an initial case concerning (b)(6) male patient who died after receiving treatment with synvisc one for osteoarthritis.Since the date of death is unknown therefore the causal role of synvisc one cannot be completely excluded for the event.However the lack of information regarding the underlying medical history, concomitant medications used by the patient, autopsy findings and the further information lack regarding the autopsy details precludes the complete case assessment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE (SYNVISC ONE)
Type of Device
INTRA-ARTICULAR HYALURONIC ACID
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
ridgefield NJ
Manufacturer Contact
kristen sharma, md
55 corp. dr.
mail stop: 55c-235a
bridgewater, NJ 08807
9089812784
MDR Report Key4359655
MDR Text Key5116089
Report Number2246315-2014-70484
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
PMA/PMN Number
P940015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Consumer
Type of Report Initial
Report Date 12/08/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Lot NumberS13061
Initial Date Manufacturer Received 12/08/2014
Initial Date FDA Received12/17/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CON MEDS = UNK; PREV MEDS = UNK
Patient Outcome(s) Death;
Patient Age64 YR
-
-